FeesSafety
Pluang+

Lazard launches three actively managed fixed income ETFs targeting US high yield, financial hybrids, and non-dollar bonds.

09 Nov 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
Lazard launches three actively managed fixed income ETFs targeting US high yield, financial hybrids, and non-dollar bonds.

Lazard Asset Management has introduced three new actively managed fixed income ETFs: Lazard US High Yield ETF, Lazard Hybrid Financial Income ETF, and Lazard Non-Dollar Active Income ETF. These ETFs provide investors access to specialized bond markets including below investment grade US corporate bonds, hybrid securities from financial institutions, and emerging market local currency bonds. The launch expands Lazard's ETF offerings to 10 products in the US with over $2 billion in assets under management, offering diversified income opportunities amid evolving market conditions. Each ETF is managed by experienced teams focusing on income, risk management, and market-specific strategies.

Lazard Asset Management's launch of three new fixed income ETFs provides fresh options for income-focused investors. For readers following the US stock market, here is Pluang's market snapshot as of Nov 09, 2026 17:51 WIB: out of 150 priced US stocks tradable on Pluang, 125 rose and 24 fell today. Notable movers include COIN at USD 130.99 with a -2.80% change and a typical hold time of 80 days, AMD at USD 461.58 up 2.79% with a 94-day hold, and PLUG at USD 1.49 up 2.76% with a 43-day hold.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App